Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Mycophenolate Mofetil

    ... aplastic anemia Mycophenolate mofetil is approved by the U.S. Food and Drug Administration (FDA) to prevent ...

    Drug last updated 03/24/2016 - 12:32pm.

  2. Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

    ... trial studies the side effects and how well sirolimus and mycophenolate mofetil work in preventing graft versus host disease (GvHD) in patients with ...

    Clinical Trial last updated 05/03/2016 - 11:35am.

  3. Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant

    ... trial studies how well sirolimus, cyclosporine and mycophenolate mofetil works in preventing graft-vs-host disease (GVHD) in patients with ...

    Clinical Trial last updated 04/28/2016 - 12:07pm.

  4. Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerou

    ... receive cyclophosphamide IV over 1 hour on days 3 and 4, and mycophenolate mofetil orally (PO) every 8 hours on days 5-30 then twice daily (BID) to day ...

    Clinical Trial last updated 04/26/2016 - 2:09pm.

  5. Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

    ... with tacrolimus and methotrexate compared to tacrolimus, mycophenolate mofetil and a reduced-dose methotrexate in patients with hematologic ... MMF 45 mg/kg/day (15mg/kg IV three times a day). Other Names: Cellcept MMF Drug: Methotrexate (low dose) MTX 5mg/m2 IV on day +1, +3, ...

    Clinical Trial last updated 04/29/2016 - 2:26pm.

  6. Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

    ... Fludarabine Mycophenolate Mofetil Phase:  Phase 2 ...

    Clinical Trial last updated 05/03/2016 - 11:45am.

  7. Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

    ... fludarabine phosphate (FLU), cyclosporine (CSP), mycophenolate mofetil (MMF), or sirolimus before transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:49pm.

  8. Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

    ... the body's normal cells. Giving cyclosporine and mycophenolate mofetil after the transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 12:13pm.

  9. Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    ... Fludarabine Mycophenolate Mofetil Phase:  Phase 2 ...

    Clinical Trial last updated 05/03/2016 - 10:51am.

  10. Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

    ... Cyclosporine Fludarabine Mycophenolate Mofetil Phase:  Phase 2 ...

    Clinical Trial last updated 05/03/2016 - 9:44am.